FI923025A0 - Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus - Google Patents

Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus

Info

Publication number
FI923025A0
FI923025A0 FI923025A FI923025A FI923025A0 FI 923025 A0 FI923025 A0 FI 923025A0 FI 923025 A FI923025 A FI 923025A FI 923025 A FI923025 A FI 923025A FI 923025 A0 FI923025 A0 FI 923025A0
Authority
FI
Finland
Prior art keywords
diagnosing
use therewith
birth time
reagent packaging
reagent
Prior art date
Application number
FI923025A
Other languages
English (en)
Swedish (sv)
Other versions
FI94181B (fi
FI94181C (fi
FI923025A (fi
Inventor
Eeva-Marja Rutanen
Original Assignee
Medix Biochemica Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medix Biochemica Ab Oy filed Critical Medix Biochemica Ab Oy
Publication of FI923025A0 publication Critical patent/FI923025A0/fi
Priority to FI923025A priority Critical patent/FI94181C/fi
Priority to EP93914749A priority patent/EP0648335B1/en
Priority to DE69328301T priority patent/DE69328301T2/de
Priority to DK93914749T priority patent/DK0648335T3/da
Priority to KR1019940704695A priority patent/KR100242876B1/ko
Priority to AU45023/93A priority patent/AU674327B2/en
Priority to ES93914749T priority patent/ES2144005T3/es
Priority to JP6502075A priority patent/JP3014451B2/ja
Priority to PCT/FI1993/000275 priority patent/WO1994000765A1/en
Priority to CA002139309A priority patent/CA2139309C/en
Publication of FI923025A publication Critical patent/FI923025A/fi
Priority to NO19945017A priority patent/NO319886B1/no
Publication of FI94181B publication Critical patent/FI94181B/fi
Application granted granted Critical
Publication of FI94181C publication Critical patent/FI94181C/fi
Priority to US11/048,685 priority patent/US20050136490A1/en
Priority to US12/498,830 priority patent/US20090269782A1/en
Priority to US12/649,156 priority patent/US7892774B2/en
Priority to US13/366,200 priority patent/US20120135432A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
FI923025A 1992-06-29 1992-06-29 Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus FI94181C (fi)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FI923025A FI94181C (fi) 1992-06-29 1992-06-29 Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
JP6502075A JP3014451B2 (ja) 1992-06-29 1993-06-29 分娩感受性を決定する診断方法およびその方法に使用する試薬キット
CA002139309A CA2139309C (en) 1992-06-29 1993-06-29 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
DE69328301T DE69328301T2 (de) 1992-06-29 1993-06-29 Diagnostisches verfahren zur bestimmung, ob die entbindung bevorsteht, und reagenzkit zur verwendung dafür
DK93914749T DK0648335T3 (da) 1992-06-29 1993-06-29 Diagnostisk fremgangsmåde til bestemmelse af fødselstilbøjeligheden og reagenskit til anvendelse dertil
KR1019940704695A KR100242876B1 (ko) 1992-06-29 1993-06-29 분만예정시기를 결정하는 진단방법과 이목적에 사용되는 키트
AU45023/93A AU674327B2 (en) 1992-06-29 1993-06-29 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
ES93914749T ES2144005T3 (es) 1992-06-29 1993-06-29 Procedimiento de diagnostico para determinar la propension al parto y el equipo de reactivos para el uso del mismo.
EP93914749A EP0648335B1 (en) 1992-06-29 1993-06-29 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
PCT/FI1993/000275 WO1994000765A1 (en) 1992-06-29 1993-06-29 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
NO19945017A NO319886B1 (no) 1992-06-29 1994-12-23 In vitro anvendelse av et stoff som binder spesifikt insulinlignende vekstfaktorbindende protein 1 og in vitro diagnostisk fremgangsmate for a bestemme mottageligheten for forlosning.
US11/048,685 US20050136490A1 (en) 1992-06-29 2005-01-31 Diagnostic method for determining the susceptibility to delivery and reagent kit for use thereof
US12/498,830 US20090269782A1 (en) 1992-06-29 2009-07-07 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
US12/649,156 US7892774B2 (en) 1992-06-29 2009-12-29 Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
US13/366,200 US20120135432A1 (en) 1992-06-29 2012-02-03 Diagnostic method for determining the susceptibility to delivery and reagent kit for use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI923025A FI94181C (fi) 1992-06-29 1992-06-29 Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
FI923025 1992-06-29

Publications (4)

Publication Number Publication Date
FI923025A0 true FI923025A0 (fi) 1992-06-29
FI923025A FI923025A (fi) 1993-12-30
FI94181B FI94181B (fi) 1995-04-13
FI94181C FI94181C (fi) 1995-07-25

Family

ID=8535548

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923025A FI94181C (fi) 1992-06-29 1992-06-29 Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus

Country Status (12)

Country Link
US (4) US20050136490A1 (fi)
EP (1) EP0648335B1 (fi)
JP (1) JP3014451B2 (fi)
KR (1) KR100242876B1 (fi)
AU (1) AU674327B2 (fi)
CA (1) CA2139309C (fi)
DE (1) DE69328301T2 (fi)
DK (1) DK0648335T3 (fi)
ES (1) ES2144005T3 (fi)
FI (1) FI94181C (fi)
NO (1) NO319886B1 (fi)
WO (1) WO1994000765A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94181C (fi) * 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
FI981049A (fi) * 1998-05-12 1999-11-13 Medix Biochemica Ab Oy Menetelmä ja koeväline kohdunkaulan kypsyyden arvioimiseksi IGFBP-1:n fosforyloiduilla isomuodoilla
CA2533915C (en) 2002-08-13 2020-09-22 N-Dia, Inc. Devices and methods for detecting amniotic fluid in vaginal secretions
GB2409720B (en) * 2002-10-08 2007-05-09 Tara Nylese Portable diagnostic device and method for determining temporal variations in concentrations
US20050191704A1 (en) * 2004-03-01 2005-09-01 Kimberly-Clark Worldwide, Inc. Assay devices utilizing chemichromic dyes
US7943294B2 (en) 2004-07-30 2011-05-17 Hologic, Inc. Methods for detecting oncofetal fibronectin
CA2830223A1 (en) 2011-03-17 2012-09-20 Cedars-Sinai Medical Center Diagnostic biomarker to predict women at risk for preterm delivery
JP6465812B2 (ja) 2013-01-02 2019-02-06 キアゲン・サイエンシズ・エル・エル・シー 妊婦において分娩までの時間を予測するための方法
US9677975B2 (en) 2014-10-31 2017-06-13 General Electric Company Systems and methods for aseptic sampling
FR3048287B1 (fr) * 2016-02-26 2018-03-23 Biosynex Procede de detection d'accouchement imminent
US10935555B2 (en) 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor
US10656164B2 (en) 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth
CN109374906A (zh) * 2018-10-23 2019-02-22 深圳市慧思基因科技有限公司 Igf-i及igfbp-1在检测卵子质量中的应用
EP3786977A1 (de) 2019-08-29 2021-03-03 WPmed GbR Computerimplementiertes verfahren und elektronisches system zur prognose eines entbindungszeitpunkts

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738177A1 (de) * 1987-11-10 1989-05-18 Siemens Ag Vermittlungsknoten fuer die vermittlung von in datenpaketen uebertragenen datensignalen
CA1337394C (en) * 1987-11-17 1995-10-24 Nelson N. H. Teng Vaginal sample test and reagents
US5096830A (en) * 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
US4952517A (en) * 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
US5258287A (en) 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
US5037735A (en) * 1988-06-24 1991-08-06 Microgenics Corporation Visual discrimination qualitative enzyme complementation assay
EP0424416B1 (en) 1988-07-15 1995-07-19 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US5252459A (en) * 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
EP0472725B1 (en) * 1990-03-16 1997-05-21 Applied Research Systems Ars Holding N.V. Treatment of polycystic ovarian disease
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
FI94181C (fi) * 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
FI981049A (fi) 1998-05-12 1999-11-13 Medix Biochemica Ab Oy Menetelmä ja koeväline kohdunkaulan kypsyyden arvioimiseksi IGFBP-1:n fosforyloiduilla isomuodoilla

Also Published As

Publication number Publication date
EP0648335B1 (en) 2000-04-05
JP3014451B2 (ja) 2000-02-28
KR950702308A (ko) 1995-06-19
DE69328301T2 (de) 2000-09-14
AU674327B2 (en) 1996-12-19
KR100242876B1 (ko) 2000-03-02
JPH07508344A (ja) 1995-09-14
FI94181B (fi) 1995-04-13
DK0648335T3 (da) 2000-07-03
CA2139309C (en) 2004-08-31
NO945017D0 (no) 1994-12-23
CA2139309A1 (en) 1994-01-06
FI94181C (fi) 1995-07-25
US20050136490A1 (en) 2005-06-23
ES2144005T3 (es) 2000-06-01
EP0648335A1 (en) 1995-04-19
DE69328301D1 (de) 2000-05-11
AU4502393A (en) 1994-01-24
FI923025A (fi) 1993-12-30
US20120135432A1 (en) 2012-05-31
US7892774B2 (en) 2011-02-22
WO1994000765A1 (en) 1994-01-06
NO945017L (no) 1994-12-23
NO319886B1 (no) 2005-09-26
US20100099117A1 (en) 2010-04-22
US20090269782A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
FI923025A0 (fi) Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
ATE186403T1 (de) Verfahren und testgerät zum nachweis von freiem igfbp-1
NO930770L (no) Immunologisk fremgangsmaate for bestemmelse av et hemoglobinderivat
Ungar et al. Activation of profibrinolysin by antigen-antibody reaction and by anaphylactoid agents; its relation to complement
Lauwerys et al. Characterization of cadmium proteinuria in man and rat.
EP0565541B1 (en) Diagnostic method for detecting the rupture of fetal membranes and test kit employing the method
WO1995030150B1 (en) Method for detecting free igfbp-1
AR075511A2 (es) Polipeptidos bopag (glicoproteina asociada a la prenez en bovinos) y acidos nucleicos que los codifican
WILLIAMS et al. Diagnosis of canine exocrine pancreatic insufficiency by the assay of serum trypsin‐like immunoreactivity
EP0064274A1 (en) Method for assaying antigen-antibody reactions and reagent therefor
AU673478B2 (en) Assay for the determination of protein in a biological sample
Kawasaki et al. Protein analyses and reagents: microscale assay of calcium-binding activity of proteins and peptides using a nitrocellulose membrane
US6210912B1 (en) Method for examining chronic rejection reactions following organ transplantation and method for determining urine components
Spillmann et al. Canine faecal pancreatic elastase (cE1) in dogs with clinical exocrine pancreatic insufficiency, normal dogs and dogs with chronic enteropathies
DE3781323D1 (de) Verfahren und testsatz zur diagnose von pflanzenkrankheiten.
Roberts et al. Assay of thyroxine-binding globulin by polyacrylamide electrophoresis: normal values
CN208459404U (zh) 一种的免疫层析联合检测卡
IE55289B1 (en) Composition and method for detecting antistreptolysin o
AU741858B2 (en) Process and device for determining the activity of enzymes in liquids
Chan et al. Formation of nonspecific precipitants in sera by counterimmunoelectrophoresis
Lown et al. Application of the proteolytic enzyme papain in routine platelet serology
Pledger The assay of oncodevelopmental proteins: Their use in foetoplacental function monitoring and in the diagnosis and monitoring of malignant disease
JPS5797451A (en) Measuring method for enzyme immunity by both sides combination method of proteinic high molecular antigen using regenerable immune adsorption body
McCann et al. Conditions for a radioimmunoassay of serum parathyroid hormone
Pena et al. Reagent strip for semiquantitative total and specific IgE measurement: A comparison to radioisotopic methods

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired